Residual pulmonary nodules after combination chemotherapy of testicular cancer.
- 1 January 1983
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 146 (1) , 195-197
- https://doi.org/10.1148/radiology.146.1.6184742
Abstract
Metastatic pulmonary lesions from germ cell testicular cancer may persist after cisplatin-based chemotherapy and may be interpreted as evidence of residual cancer if levels of the tumor markers .alpha.-fetoprotein and human chorionic gonadotropin have normalized during therapy. Mature teratoma will be found in .apprx. 25% of the specimens that are resected. Pathologic documentation of malignancy is recommended.This publication has 9 references indexed in Scilit:
- Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreductionCancer, 1981
- Combined chemotherapy and surgery in treatment of advanced germ-cell tumorsCancer, 1981
- Non‐seminoma Germ Cell Tumours (Malignant Teratoma) of the Testis Results of Treatment and an Analysis of Prognostc Factors*British Journal of Urology, 1981
- Tumor markers in advanced nonseminomatous testicular cancerCancer, 1981
- Vinblastine, bleomycin and Cis-diamminedichloroplatinum in disseminated testicular cancer: Response to treatment and prognostic correlationsPublished by Elsevier ,1980
- COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMAThe Lancet, 1979
- The induction of differentiation in teratocarcinoma stem cells by retinoic acidCell, 1978
- The evolution of mature teratoma from malignant testicular tumorsCancer, 1977
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977